ACLX has 36-month beta value of 0.27. Analysts have mixed views on the stock, with 12 analysts rating it as a “buy,” 6 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ACLX is 39.50M, and currently, short sellers hold a 16.65% ratio of that float. The average trading volume of ACLX on June 19, 2025 was 757.45K shares.
ACLX) stock’s latest price update
Arcellx Inc (NASDAQ: ACLX)’s stock price has plunge by 1.49relation to previous closing price of 62.88. Nevertheless, the company has seen a -3.55% plunge in its stock price over the last five trading sessions. businesswire.com reported 2025-05-21 that REDWOOD CITY, Calif.–(BUSINESS WIRE)–Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced two upcoming investor events: TD Cowen’s 6th Annual Oncology Innovation Summit Tuesday, May 27, 2025 at 9:00 a.m. PT (Virtual) Management and Physician Presentation and Discussion of iMMagine-1 Pivotal Study Results During EHA2025 Friday, June 13, 2025 at.
ACLX’s Market Performance
Arcellx Inc (ACLX) has experienced a -3.55% fall in stock performance for the past week, with a 9.08% rise in the past month, and a -10.55% drop in the past quarter. The volatility ratio for the week is 1.90%, and the volatility levels for the past 30 days are at 2.85% for ACLX. The simple moving average for the last 20 days is -1.31% for ACLX stock, with a simple moving average of -12.77% for the last 200 days.
Analysts’ Opinion of ACLX
Many brokerage firms have already submitted their reports for ACLX stocks, with Citigroup repeating the rating for ACLX by listing it as a “Buy.” The predicted price for ACLX in the upcoming period, according to Citigroup is $110 based on the research report published on June 17, 2025 of the current year 2025.
Redburn Atlantic, on the other hand, stated in their research note that they expect to see ACLX reach a price target of $109. The rating they have provided for ACLX stocks is “Buy” according to the report published on October 08th, 2024.
ACLX Trading at 2.79% from the 50-Day Moving Average
After a stumble in the market that brought ACLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.56% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ACLX starting from Patel Kavita, who sale 1,500 shares at the price of $67.36 back on Jun 10 ’25. After this action, Patel Kavita now owns 0 shares of Arcellx Inc, valued at $101,040 using the latest closing price.
KAVITA K PATEL, the Director of Arcellx Inc, proposed sale 1,500 shares at $66.86 during a trade that took place back on Jun 10 ’25, which means that KAVITA K PATEL is holding shares at $100,290 based on the most recent closing price.
Stock Fundamentals for ACLX
Current profitability levels for the company are sitting at:
- -2.48 for the present operating margin
- 0.98 for the gross margin
The net margin for Arcellx Inc stands at -2.11. The total capital return value is set at -0.36. Equity return is now at value -35.56, with -22.75 for asset returns.
Based on Arcellx Inc (ACLX), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at -2.16. The debt to equity ratio resting at 0.13. The interest coverage ratio of the stock is -419.95.
Currently, EBITDA for the company is -99.06 million with net debt to EBITDA at 0.17. When we switch over and look at the enterprise to sales, we see a ratio of 45.43. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.93.
Conclusion
To put it simply, Arcellx Inc (ACLX) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
